Sign In
Buy FBT
$229.79
+0.96 (+0.420%)
At Close: Jun 22, 2026
Top-Performing Biotech ETFs of Last Week
12:02pm, Monday, 14'th Jun 2021
Investors may want to tap the bullishness in the sector with the best biotech ETFs of last week.
Will Biotech ETFs Benefit from Biogen's New Alzheimer's Drug?
09:54am, Wednesday, 09'th Jun 2021
Biotech investors may have reason to celebrate this week, as the FDA approved Biogen's Alzheimer's disease drug Aducanumab on Monday, ushering in the first medication to be allowed by U.S. regulators
Top COVID-19 Vaccine Stories of May Put Biotech ETFs in Focus
04:32pm, Tuesday, 01'st Jun 2021
Let's take a look at some top coronavirus vaccine stories of May and the possible impact they can have on biotech ETFs.
Biotech ETFs to Suffer as US Backs IP Waiver for COVID-19 Vaccines
06:02pm, Friday, 07'th May 2021
The Biden administration recently informed about supporting the waiver of intellectual property protections for COVID-19 vaccines that has been proposed by South Africa and India.
Top COVID-19 Vaccine Stories of April Put Biotech ETFs in Focus
04:32pm, Tuesday, 04'th May 2021
Let's take a look at some top coronavirus vaccine stories of April and the possible impact they can have on biotech ETFs.
Biotech Innovations Remain At Forefront
11:10am, Friday, 16'th Apr 2021
The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r
Moving Beyond COVID In Biopharma
09:31am, Thursday, 15'th Apr 2021
Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,
Top COVID-19 Vaccine Stories of March Put Biotech ETFs in Focus
06:10pm, Thursday, 08'th Apr 2021
Investors are closely tracking the progress in coronavirus vaccine development amid the pandemic's renewed resurgence with multiple mutants.
A Guide to Biotech ETF Investing Amid the Coronavirus Crisis
02:18pm, Tuesday, 12'th Jan 2021
The biotech space had an impressive run on the bourses in 2020 as the coronavirus pandemic triggered a race to roll out vaccine and treatment.
ETF Market Outlook & Picks for 2021
04:33pm, Friday, 08'th Jan 2021
Two ETF experts share their market outlook and top picks for 2021.
ETFs to Tap AstraZeneca Mega-Deal to Buy Alexion
11:17am, Tuesday, 15'th Dec 2020
AstraZeneca has agreed to buy rare-disease specialist Alexion Pharmaceuticals for $39 billion. The deal would represent the biggest transaction in pharmaceuticals since 2019.
3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover
08:29am, Monday, 14'th Dec 2020
The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a $39-billion takeover of Alexi
ETF Sectors to Bet on Positive Vaccine News
02:25pm, Thursday, 26'th Nov 2020
The introduction of the coronavirus vaccine is expected to help in the economic recovery, especially for sectors which have taken a hit from the social-distancing and lockdown measures.
Can't Get Enough Biotech Exposure in Your Portfolio?
12:38pm, Thursday, 29'th Oct 2020
As coronavirus cases start to tick upwards once more, the race to create a vaccine will only intensify, boding well for the biotechnology sector. ETF investors may want to keep an eye on biotech funds
Biotech ETFs at multi-week highs, extending winning streak
01:45pm, Tuesday, 27'th Oct 2020
Biotechnology exchange-traded funds outperformed Tuesday as investors focused on next-generation solutions to the coronavirus and more. The ARK Genomic Revolution ETF was up 2.2% in the early afternoo
